Syneos Health Reports Fourth Quarter and Full Year 2021 Results
February 17, 2022 06:10 ET
|
Syneos Health, Inc.
Highlights Fourth quarter revenue of $1,373.4 million increased 20.5% year-over-year.Clinical Solutions net new business awards and book-to-bill ratios: Including reimbursable out-of-pocket expenses,...
Syneos Health Appoints Two New Independent Directors
January 18, 2022 06:16 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Jan. 18, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced it has appointed two new...
Syneos Health Releases 2022 Dealmakers’ Intentions Survey
January 11, 2022 09:00 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Jan. 11, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today released its 12th annual Dealmakers’...
Takeda’s Area Offices in Dubai, United Arab Emirates Certified Sustainable and Inaugurated
November 16, 2021 07:53 ET
|
Takeda Pharmaceuticals
Dubai, United Arab Emirates, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Recognizing that climate change poses a risk to human health, including the spread of infectious diseases, Takeda has made...